导航

| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -0.79% | 1927/3841 |
| 近一周 | -2.14% | 1068/4400 |
| 近一月 | -3.93% | 1681/4368 |
| 近一季 | -6.68% | 1750/4194 |
| 近半年 | -1.72% | 1357/3957 |
| 近一年 | 2.14% | 1771/3534 |
| 近两年 | 47.93% | 1287/2480 |
| 近三年 | 30.45% | 843/1874 |
| 成立以来 | 29.36% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-3.48% 3235/4961 |
12.48% 2172/5312 |
- - |
- - |
| 2025 | 20.52% 2114/4813 |
-0.84% 2426/3635 |
2.28% 1687/4076 |
18.13% 2344/4524 |
0.59% 1911/4813 |
| 2024 | 17.06% 732/3463 |
2.82% 692/2808 |
-1.10% 932/3014 |
16.75% 1362/3129 |
-1.40% 1690/3463 |
| 2023 | -8.43% 1014/2656 |
4.33% 977/2280 |
-3.64% 854/2385 |
-2.72% 726/2515 |
-6.37% 1742/2655 |
| 2022 | -17.75% 627/2207 |
-13.70% 819/1919 |
6.88% 583/2016 |
-13.12% 835/2113 |
2.63% 878/2208 |
| 2021 | -1.14% 783/1822 |
-2.60% 674/1255 |
4.26% 906/1330 |
-4.94% 754/1466 |
2.41% 598/1822 |
| 2020 | 33.41% 459/1250 |
-9.49% 682/1028 |
13.53% 612/1067 |
14.23% 290/1164 |
13.66% 342/1184 |
| 2019 | 36.39% 359/1092 |
26.24% 419/754 |
-0.17% 230/804 |
0.96% 440/850 |
7.18% 472/918 |
| 2018 | -22.53% 243/834 |
- - |
- - |
- - |
-11.74% 344/691 |
| 2017 | 22.45% 149/714 |
- - |
- - |
- - |
- - |
| 2016 | -7.82% 229/605 |
- - |
- - |
- - |
- - |
| 2015 | 7.27% 176/575 |
- - |
- - |
- - |
- - |
| 2014 | 46.05% 104/237 |
- - |
- - |
- - |
- - |
| 2013 | -5.81% 105/186 |
- - |
- - |
- - |
- - |
| 2012 | 7.92% 61/140 |
- - |
- - |
- - |
- - |
| 2011 | -23.57% 61/102 |
- - |
- - |
- - |
- - |
| 2010 | -11.67% 26/58 |
- - |
- - |
- - |
- - |
| 2009 | 89.60% 9/27 |
- - |
- - |
- - |
- - |
| 2008 | -62.61% 14/26 |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 天弘恒生沪深港创新药精选50ETF | 0.8428 | 28.18% |
| 港股通药 | 0.8930 | 27.53% |
| 天弘恒生沪深港创新药精选50ETF发起联接A | 1.2971 | 26.78% |
| 华富中证港股通创新药指数型发起式C | 1.1445 | 26.30% |
| 万家中证港股通创新药ETF | 1.5973 | 26.27% |
| 景顺长城中证港股通创新药ETF | 1.6587 | 26.20% |
| 天弘恒生沪深港创新药精选50ETF发起联接C | 1.2831 | 25.87% |
| 港医疗 | 0.8885 | 25.59% |
| 景顺长城中证港股通创新药ETF联接A | 1.4594 | 25.50% |
| 华富中证港股通创新药指数型发起式A | 1.1526 | 25.42% |
| 国泰沪深300指数A VS. 长安沪深300非周期A(740101) |